Overactive Bladder
Racial differences in the prevalence of overactive bladder in the United States from the epidemiology of LUTS (EpiLUTS) study - Abstract
November 17, 2011
Unexpected frequent hepatotoxicity of a prescription drug, flupirtine, marketed for about 30 years - Abstract
November 15, 2011
Controversy over the pharmacological treatments of storage symptoms in spinal cord injury patients: A literature overview - Abstract
November 14, 2011
Antimuscarinic effects on current perception threshold: A prospective placebo control study - Abstract
November 11, 2011
A healthy bladder: a consensus statement - Abstract
November 11, 2011
SUmiT Trial outcomes: Clinical insights into percutaneous tibial nerve stimulation - Abstract
November 9, 2011
Updates in the management of the overactive bladder in patients with myelomeningocele - Abstract
November 8, 2011
Time-to-effect with darifenacin in overactive bladder: A pooled analysis - Abstract
November 7, 2011
Botulinum toxin treatment for overactive bladder and detrusor overactivity in adults - Abstract
November 4, 2011
Participation of the pudendal innervation in the detrusor overactivity of the detrusor and in the overactive bladder syndrome - Abstract
November 2, 2011
Antibodies after botulinum toxin A injection into musculus detrusor vesicae: Incidence and clinical relevance - Abstract
November 1, 2011
Solifenacin objectively decreases urinary sensation in women with overactive bladder syndrome - Abstract
October 31, 2011
Treating overactive bladder in the elderly - Abstract
October 28, 2011